Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    303-97-9

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 303-97-9, Ubiquinone 9, Ubiquinone-9, Coq9, Ubiquinone 45, Ubiquinone q9
    Molecular Formula
    C54H82O4
    Molecular Weight
    795.2  g/mol
    InChI Key
    UUGXJSBPSRROMU-WJNLUYJISA-N
    FDA UNII
    MGW7TYF2DQ
    ubiquinone-9 is a natural product found in Hevea brasiliensis, Pleurotus eryngii, and other organisms with data available.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    2,3-dimethoxy-5-methyl-6-[(2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl]cyclohexa-2,5-diene-1,4-dione
    2.1.2 InChI
    InChI=1S/C54H82O4/c1-40(2)22-14-23-41(3)24-15-25-42(4)26-16-27-43(5)28-17-29-44(6)30-18-31-45(7)32-19-33-46(8)34-20-35-47(9)36-21-37-48(10)38-39-50-49(11)51(55)53(57-12)54(58-13)52(50)56/h22,24,26,28,30,32,34,36,38H,14-21,23,25,27,29,31,33,35,37,39H2,1-13H3/b41-24+,42-26+,43-28+,44-30+,45-32+,46-34+,47-36+,48-38+
    2.1.3 InChI Key
    UUGXJSBPSRROMU-WJNLUYJISA-N
    2.1.4 Canonical SMILES
    CC1=C(C(=O)C(=C(C1=O)OC)OC)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C
    2.1.5 Isomeric SMILES
    CC1=C(C(=O)C(=C(C1=O)OC)OC)C/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CCC=C(C)C
    2.2 Other Identifiers
    2.2.1 UNII
    MGW7TYF2DQ
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 2,5-cyclohexadiene-1,4-dione, 2,3-dimethoxy-5-methyl-6-((2e,6e,10e,14e,18e,22e,26e,30e)-3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaen-1-yl)-

    2. Coq9

    3. Ubiquinone 9

    4. Ubiquinone 9, (z,z,z,z,z,e,e,e)-isomer

    5. Ubiquinone Q-9

    6. Ubiquinone-9

    2.3.2 Depositor-Supplied Synonyms

    1. 303-97-9

    2. Ubiquinone 9

    3. Ubiquinone-9

    4. Coq9

    5. Ubiquinone 45

    6. Ubiquinone Q9

    7. Ubiquinone-45

    8. Coenzyme Q(sub 9)

    9. Ubiquinone Q(sub 9)

    10. Coq(sub 9)

    11. Coenzyme Q(9)

    12. Mgw7tyf2dq

    13. Chebi:18160

    14. Nsc-226993

    15. 2,3-dimethoxy-5-methyl-6-[(2e,6e,10e,14e,18e,22e,26e,30e)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl]cyclohexa-2,5-diene-1,4-dione

    16. Unii-mgw7tyf2dq

    17. Nsc 226993

    18. Brn 1900081

    19. Ubiquinone9

    20. Coenzyme-q9

    21. Ubiquinone(9)

    22. 2,3-dimethoxy-5-methyl-6-((2e,6e,10e,14e,18e,22e,26e,30e)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaen-1-yl)cyclohexa-2,5-diene-1,4-dione

    23. 2,3-dimethoxy-5-methyl-6-[(2e,6e,10e,14e,18e,22e,26e,30e)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaen-1-yl]cyclohexa-2,5-diene-1,4-dione

    24. Mfcd00056635

    25. Ubiquinone Q9 (stn)

    26. 4-08-00-03313 (beilstein Handbook Reference)

    27. Chembl2252965

    28. Ubidecarenone Related Compound A

    29. Dtxsid601317880

    30. Zinc8217487

    31. Lmpr02010004

    32. Nsc226993

    33. Akos027307694

    34. Coenzyme Q9, >=96.0% (hplc)

    35. Cs-6359

    36. 2,5-cyclohexadiene-1,4-dione, 2,3-dimethoxy-5-methyl-6-((2e,6e,10e,14e,18e,22e,26e,30e)-3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaen-1-yl)-

    37. 2,5-cyclohexadiene-1,4-dione, 2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-, (all-e)-

    38. As-77794

    39. P-benzoquinone, 2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-

    40. P-benzoquinone, 2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)- (van)

    41. Hy-101415

    42. Ubidecarenone Impurity D [ep Impurity]

    43. C01967

    44. Ubidecarenone Related Compound A [usp-rs]

    45. J-017946

    46. 2-methyl-3-nonaprenyl-5,6-dimethoxy-1,4-benzoquinone

    47. Q27102857

    48. Ubidecarenone Impurity D, European Pharmacopoeia (ep) Reference Standard

    49. Ubidecarenone Related Compound A, United States Pharmacopeia (usp) Reference Standard

    50. (all-e)-2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-2,5-cyclohexadiene-1,4-dione

    51. 2,3-dimethoxy-5-methyl-6-[(2e,6e,10e,14e,18e,22e,26e,30e)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaen-1-yl]-1,4-benzoquinone

    52. 2,4-dione, 2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-, (all-e)-

    53. 3-methyl-5,6-dimethoxy-2-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonene-1-yl)-1,4-benzoquinone

    54. P-benzoquinone,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-

    2.4 Create Date
    2004-09-16
    3 Chemical and Physical Properties
    Molecular Weight 795.2 g/mol
    Molecular Formula C54H82O4
    XLogP317.6
    Hydrogen Bond Donor Count0
    Hydrogen Bond Acceptor Count4
    Rotatable Bond Count28
    Exact Mass794.62131109 g/mol
    Monoisotopic Mass794.62131109 g/mol
    Topological Polar Surface Area52.6 Ų
    Heavy Atom Count58
    Formal Charge0
    Complexity1680
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count8
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Antioxidants

    Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)